MENLO TIMES

Scarlet, building a global medical device certification built for AI, led by James Dewar and Jamie Cox, has raised $50m in Series B funding, led by Headline, with participation from existing investors Kindred Capital, Creandum, Atomico, and Entrepreneurs First (EF), and new investor Notion Capital. Scarlet is accelerating AI medical device certification, helping developers cut a year or more from certification timelines and reduce product-update cycles from months to weeks a

Causa Prima, the agent-to-agent platform for enterprise finance, led by Maex Ament, Henrik Gebbing, and Philip Stanislaus, has raised a $20 million seed round that closed in September to expand its agent-to-agent platform, led by Base10 Partners, with participation from QED Investors, FJ Labs, and existing investors Creandum, Kfund, and Borusan Ventures. The company previously raised $10 million in a pre-seed round, bringing its total funding to $30 million. “The status quo t

PRIMA, a wireless brain-computer interface implant, is now commercially available in Europe for patients with vision loss caused by geographic atrophy. In a New England Journal of Medicine study, 84% of 32 patients assessed at 12 months reported being able to read letters, numbers, and words. The technology is now being trialled for Stargardt disease and retinitis pigmentosa. In the PRIMAlia trial at Sydney Eye Hospital, the first Stargardt patient received the implant in May